Review: taking Fluoxetine hydrochloride and Ondansetron together


Summary

Drug interactions are reported among people who take Fluoxetine hydrochloride and Ondansetron together. This review analyzes the effectiveness and drug interactions between Fluoxetine hydrochloride and Ondansetron. It is created by eHealthMe based on reports of 1,252 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Fluoxetine hydrochloride and Ondansetron >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Fluoxetine Hydrochloride

Fluoxetine hydrochloride has active ingredients of fluoxetine hydrochloride. It is often used in depression. (latest outcomes from Fluoxetine hydrochloride 4,802 users)

Ondansetron

Ondansetron has active ingredients of ondansetron. It is often used in nausea. (latest outcomes from Ondansetron 18,009 users)

On Aug, 30, 2016

1,252 people who take Fluoxetine Hydrochloride, Ondansetron are studied.


Number of reports submitted per year:

Fluoxetine hydrochloride and Ondansetron drug interactions.

Drug effectiveness over time:

Fluoxetine Hydrochloride:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 100.0% - (5 of 5 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 3 people)
  • not specified: 0.0% - (0 of 0 people)
Ondansetron:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Fluoxetine Hydrochloride:
  • female: 35.0% - (6 of 17 people)
  • male: 0.0% - (0 of 2 people)
Ondansetron:
  • female: 42.0% - (6 of 14 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Fluoxetine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 40.0% - (2 of 5 people)
  • 30-39: 50.0% - (2 of 4 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 0.0% - (0 of 2 people)
Ondansetron:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 60.0% - (3 of 5 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 0.0% - (0 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • vomiting
  • tremor
  • nausea
  • hypotension
  • pyrexia
  • serotonin syndrome
  • tachycardia
  • coma scale abnormal
  • dehydration
1 - 6 months:
  • enterocolitis
  • idiopathic thrombocytopenic purpura
  • small intestinal obstruction
  • drug exposure during pregnancy
  • pain
  • renal failure
  • acute pulmonary oedema
  • fatigue
  • injury
  • respiratory failure
6 - 12 months:
  • talipes
  • calculus urinary
  • drug exposure during pregnancy
  • renal impairment
  • anaemia
  • maternal drugs affecting foetus
  • renal failure
  • thrombocytopenia
  • tumour embolism
  • abdominal discomfort
1 - 2 years:
  • drug exposure during pregnancy
  • hypotension
  • tremor
  • abasia
  • abdominal pain
  • abdominal pain aggravated
  • abscess
  • acne
  • alanine aminotransferase increased
  • alopecia
2 - 5 years:
  • pain
  • cholecystitis chronic
  • emotional distress
  • anxiety
  • gallbladder disorder
  • pancreatitis
  • sphincter of oddi dysfunction
  • bipolar disorder
  • deep vein thrombosis
  • depression
5 - 10 years:
  • chronic pain
  • abdominal pain lower
  • anxiety
  • depression
  • device dislocation
  • emotional distress
  • genital haemorrhage
  • infertility female
  • injury
  • medical device complication
10+ years:
  • apnea - sleep apnea syndrome
  • balance disorder
  • breast cancer female
  • breast cancer metastatic
  • depression
  • dizziness
  • drug ineffective
  • impairment of speech
  • intolerance to cold
  • intolerance to heat
not specified:
  • pain
  • anxiety
  • nausea
  • pyrexia
  • back pain
  • arthralgia
  • dyspnoea
  • depression
  • fatigue
  • osteonecrosis of jaw

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • anxiety
  • pyrexia
  • back pain
  • dyspnoea
  • injury
  • arthralgia
  • fatigue
  • vomiting
male:
  • anxiety
  • dehydration
  • arthralgia
  • depression
  • pyrexia
  • pain
  • dyspnoea
  • nausea
  • back pain
  • osteoarthritis

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • drug exposure via breast milk
  • premature baby
  • depression
  • enamel anomaly
  • irritable bowel syndrome
  • maternal drugs affecting foetus
  • premature labour
  • vomiting
  • constipation
2-9:
  • b-cell lymphoma
  • chronic sinusitis
  • conjunctivitis
  • cough
  • depression
  • ear infection
  • eczema
  • eczema eyelids
  • pyrexia
  • reflux oesophagitis
10-19:
  • pain
  • cholecystitis chronic
  • abdominal pain
  • anxiety
  • gallbladder disorder
  • headache
  • nausea
  • pancreatitis
  • sphincter of oddi dysfunction
  • dyspnoea
20-29:
  • nausea
  • vomiting
  • arthralgia
  • dyspnoea
  • dizziness
  • oedema peripheral
  • pain
  • depression
  • neuropathy peripheral
  • anxiety
30-39:
  • dehydration
  • deep vein thrombosis
  • pulmonary embolism
  • nausea
  • pain
  • anaemia
  • convulsion
  • drug exposure during pregnancy
  • back pain
  • depression
40-49:
  • pain
  • nausea
  • dyspnoea
  • fatigue
  • back pain
  • injury
  • pyrexia
  • anxiety
  • chest pain
  • vomiting
50-59:
  • pyrexia
  • arthralgia
  • pain
  • anxiety
  • oedema peripheral
  • back pain
  • osteonecrosis of jaw
  • cellulitis
  • injury
  • pain in extremity
60+:
  • pain
  • anxiety
  • nausea
  • back pain
  • asthenia
  • pyrexia
  • osteonecrosis of jaw
  • anaemia
  • fatigue
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Fluoxetine hydrochloride and Ondansetron?

Can you answer these questions?

More questions for: Fluoxetine hydrochloride, Ondansetron

You may be interested in these reviews

More reviews for: Fluoxetine hydrochloride, Ondansetron

On eHealthMe, Fluoxetine hydrochloride (fluoxetine hydrochloride) is often used to treat depression. Ondansetron (ondansetron) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.